Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party)-Reference-Cited by-同舟云学术

Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party)

Published:1988-06-25 Issue:6639 Volume:296 Page:1759-1761
ISSN:0959-8138
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Tolley D A,Hargreave T B,Smith P H,Williams J L,Grigor K M,Parmar M K B,Freedman L S,Uscinska B M

Publisher

BMJ

Subject

General Earth and Planetary Sciences,General Environmental Science,General Engineering

Reference18 articles.

1. ontia lc (ancrum (UICC). I NM atlas-illustrated guide to the classficaltiot o/ nmalignant tumnours;I Union International C,1982

2. Blandv J1'. Paris AMI. 'Ihe treatment of single and multiple papillarv tumors of the bladder;England, H.R.,1980

3. Benign papilloma or papillarv carcinoma of the bladder?.7 Urol;Green, L.F.; Hanash, K.A.; Farrow, G.M.,1973

4. Prognostic factors in non-infiltrating carcinoma of the bladder;Pocock, R.D.; Ptonder, B.A.J.; J1', O.'Sullivan; Ibrahim, S.K.; Easton, E.F.; Shearer, R.J.,1982

5. Prognostic parameters in superficial bladder cancer: analvsis;W, S.Lutzever; H, Rubben; H, Dahm;of,1982

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bladder cancer grading using the four‐tier combination of the World Health Organization (WHO) 1973 and WHO 2004 classifications;BJU International;2023-07-12

2. Immunotherapy for non-muscle-invasive bladder cancer: from the origins of BCG to novel therapies;Future Oncology;2022-01

3. Fanconi anemia-independent DNA inter-strand crosslink repair in eukaryotes;Progress in Biophysics and Molecular Biology;2020-12

4. Randomized Study of Postoperative Single Intravesical Instillation With Pirarubicin and Mitomycin C for Low-risk Bladder Cancer;Anticancer Research;2020-09

5. Combining two grading systems: the clinical validity and inter-observer variability of the 1973 and 2004 WHO bladder cancer classification systems assessed in a UK cohort with 15 years of prospective follow-up;World Journal of Urology;2020-04-07